Expression of the leukemic prognostic marker CD7 is linked to epigenetic modifications in chronic myeloid leukemia

BACKGROUND: Expression levels of the cell surface glycoprotein, CD7, and the serine protease, elastase 2 (ELA2), in the leukemic cells of patients with chronic myeloid leukemia (CML) have been associated with clinical outcome. However, little is known about the mechanisms that underlie the variable...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogers, Sally L, Zhao, Yun, Jiang, Xiaoyan, Eaves, Connie J, Mager, Dixie L, Rouhi, Arefeh
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2843654/
https://www.ncbi.nlm.nih.gov/pubmed/20175919
http://dx.doi.org/10.1186/1476-4598-9-41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2843654/
https://www.ncbi.nlm.nih.gov/pubmed/20175919
http://dx.doi.org/10.1186/1476-4598-9-41

Ejemplares similares